However, the frequency of EC centrosome over-duplication, even with a combination of both VEGF-A and bFGF, was much less than that seen in primary isolates of tumor-derived EC [6], suggesting that other aspects of the tumor environment contribute to pathological centrosome over-duplication. This evidence concerns the gene FGF2 and neoplasm.